266 related articles for article (PubMed ID: 15818324)
1. HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease.
Bogunia-Kubik K; Lange A
Transplantation; 2005 Apr; 79(7):815-20. PubMed ID: 15818324
[TBL] [Abstract][Full Text] [Related]
2. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
[TBL] [Abstract][Full Text] [Related]
3. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
Bogunia-Kubik K; Middleton P; Norden J; Dickinson A; Lange A
Int J Immunogenet; 2008 Jun; 35(3):207-13. PubMed ID: 18312595
[TBL] [Abstract][Full Text] [Related]
4. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
[TBL] [Abstract][Full Text] [Related]
5. Patient HSP70-hom TG haplotype is associated with decreased transplant-related mortality and improved survival after sibling HLA-matched hematopoietic stem cell transplantation.
Kim I; Kim JH; Rhee JY; Kim JW; Cho HJ; Cho EY; Lee JE; Hong YC; Park SS; Yoon SS; Park MH; Park S; Kim BK
Clin Transplant; 2010; 24(4):459-66. PubMed ID: 19758266
[TBL] [Abstract][Full Text] [Related]
6. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
7. Non-HLA gene polymorphisms and the outcome of allogeneic hemato-poietic stem cell transplantation.
Bogunia-Kubik K; Wysoczanska B; Lange A
Curr Stem Cell Res Ther; 2006 May; 1(2):239-53. PubMed ID: 18220870
[TBL] [Abstract][Full Text] [Related]
8. IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation.
Jaskula E; Lange A; Dlubek D; Kyrcz-Krzemień S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Goździk J; Mizia S;
Tissue Antigens; 2013 Dec; 82(6):387-96. PubMed ID: 24498995
[TBL] [Abstract][Full Text] [Related]
9. HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis.
Bogunia-Kubik K; Koscinska K; Suchnicki K; Lange A
Int J Immunogenet; 2006 Apr; 33(2):135-40. PubMed ID: 16611259
[TBL] [Abstract][Full Text] [Related]
10. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
Wetzel L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
[TBL] [Abstract][Full Text] [Related]
11. [Relationship of tumor necrosis factor gene polymorphism and acute graft-versus-host disease after unrelated allogeneic hematopoietic stem cell transplantation].
Jin L; Xiao HW; Lai XY; Wu GQ; Luo Y; Shi JM; Tan YM; Huang H
Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):320-4. PubMed ID: 20627040
[TBL] [Abstract][Full Text] [Related]
12. [Effects of IL10-592 locus of AA genotype on the incidence of aGVHD and survival after HLA-matched unrelated allogeneic hematopoietic stem cell transplantation].
Yang ZL; Qiu QC; Ding ZX; Pan ZJ; Zhao QQ; He J
Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):372-6. PubMed ID: 27210870
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.
Bogunia-Kubik K; Mizia S; Polak M; Gronkowska A; Nowak J; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Koclęga A; Sędzimirska M; Suchnicki K; Duda D; Lange J; Mordak-Domagała M; Kościńska K; Jędrzejczak WW; Kaczmarek B; Hellmann A; Kucharska A; Kowalczyk J; Drabko K; Warzocha K; Hałaburda K; Tomaszewska A; Mika-Witkowska R; Witkowska A; Goździk J; Mordel A; Wysoczańska B; Jaskula E; Lange A;
Cytokine; 2015 Dec; 76(2):182-186. PubMed ID: 25982843
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
[TBL] [Abstract][Full Text] [Related]
15. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
[TBL] [Abstract][Full Text] [Related]
16. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept study.
Han H; Yuan F; Sun Y; Liu J; Liu S; Luo Y; Liang F; Liu N; Long J; Zhao X; Kong F; Xi Y
Oncotarget; 2015 Nov; 6(37):40337-59. PubMed ID: 26498683
[TBL] [Abstract][Full Text] [Related]
18. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling.
El-Chennawi FA; Kamel HA; Mosaad YM; El-Sherbini SM; El-Billey NA
Hematology; 2006 Aug; 11(4):227-34. PubMed ID: 17178660
[TBL] [Abstract][Full Text] [Related]
19. TNF polymorphisms are associated with toxic but not with aGVHD complications in the recipients of allogeneic sibling haematopoietic stem cell transplantation.
Bogunia-Kubik K; Polak M; Lange A
Bone Marrow Transplant; 2003 Sep; 32(6):617-22. PubMed ID: 12953135
[TBL] [Abstract][Full Text] [Related]
20. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Bogunia-Kubik K; Duda D; Suchnicki K; Lange A
Haematologica; 2006 Dec; 91(12):1628-34. PubMed ID: 17145599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
